Lito Woman Denies Favor to Get Experimental Medicine - Tribuna Do Norte
15 Articles
15 Articles
The National Agency of Health Surveillance (Anvisa) authorized on Friday (4), the exceptional import of an experimental drug for the influencer Lito Sousa, diagnosed with Creutzfeldt-Jakob disease (DCJ), rare, rapid and no known cure. The substance, called ALN-6457, is developed by the American pharmacist Regeneron Pharmaceuticals and has not yet been formally tested in humans for the treatment of prionic disease. Without commercial registration…
Rare and unhealed brain disease mobilized the family in search of authorization for the use of experimental medicine in Brazil The post Case Lito Sousa: Anvisa authorizes the import of experimental medicine to treatment; pilot's wife rebates royalties: ‘By means of its own' apareceu primeiro em ND More
The woman of the influencer Lito Sousa, Mila Seidl, used the social networks on Saturday (5) to deny that the authorization for the use of an experimental medicine against the disease of Creutzfeldt-Jakob was obtained by favoring authorities, entrepreneurs or the National Agency of Health Surveillance (Anvisa). In the videos, Mila says [...] The post Lito woman denies favoring to obtain experimental medicine appeared first in Tribuna do Norte.
Mila Seidl denies favoring the release of experimental medicine against rare Lito Sousa disease and details legal procedures of compassionate use
Influencer was diagnosed with Creutzfeldt-Jakob disease, and struggle to obtain experimental treatment
This is how Mila Seidl celebrated this Saturday, 5, the good news of the release of the experimental medicine that the Sousa Lito family had been waiting for for weeks. Anvisa authorized on last Friday, 4, the import of the medicine for the influencer and aviation expert, diagnosed with the disease of [...]
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
